Literature DB >> 31786985

Classical Dendritic Cells Mediate Hypertension by Promoting Renal Oxidative Stress and Fluid Retention.

Xiaohan Lu1, Nathan P Rudemiller1, Jamie R Privratsky1, Jiafa Ren1, Yi Wen1, Robert Griffiths1, Steven D Crowley1,2.   

Abstract

FLT3L (Fms-like tyrosine kinase 3 ligand) stimulates the development of classical dendritic cells (DCs). Here we tested the hypothesis that classical DCs drive blood pressure elevation by promoting renal fluid retention. FLT3L-deficient (FLT3L-/-) mice that lack classical DCs in the kidney had mean arterial pressures similar to wild-types (WTs) at baseline but had blunted hypertensive responses during 4 weeks of chronic Ang II (angiotensin II) infusion. In FLT3L-/- mice, the proportions of effector memory T cells in the kidney were similar to those in WTs at baseline. However, after Ang II infusion, proportions of effector memory T cells were dramatically lower in the FLT3L-/- kidneys versus WTs, indicating that classical DCs augment the renal accumulation of effector T cells after renin-angiotensin system activation. Consistent with their lower blood pressures, the Ang II-infused FLT3L-/- mice had attenuated cardiac hypertrophy and lower renal mRNA expression for pro-hypertensive cytokines. Moreover, the Ang II-infused FLT3L-/- mice had lower urinary excretion of the oxidative stress marker 8-isoprostane and lower renal mRNA levels of nicotinamide adenine dinucleotide phosphate oxidase 2. In an intraperitoneal saline challenge test at day 7 of Ang II, FLT3L-/- mice excreted higher proportions of the injected volume and sodium than WTs. Consistent with this enhanced diuresis, mRNA expressions for the sodium chloride cotransporter and all 3 subunits of the epithelial sodium channel were diminished by >40% in FLT3L-/- kidneys compared with the WTs. Thus, classical FLT3L-dependent DCs promote renal T-cell activation with consequent oxidative stress, fluid retention, and blood pressure elevation.

Entities:  

Keywords:  dendritic cells; diuresis; hypertension; oxidative stress; sodium

Mesh:

Substances:

Year:  2019        PMID: 31786985      PMCID: PMC7004279          DOI: 10.1161/HYPERTENSIONAHA.119.13667

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  37 in total

1.  Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat.

Authors:  David L Mattson; Leilani James; Elizabeth A Berdan; Carla J Meister
Journal:  Hypertension       Date:  2006-06-05       Impact factor: 10.190

2.  A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension.

Authors:  Jian-dong Zhang; Mehul B Patel; Young-Soo Song; Robert Griffiths; James Burchette; Phillip Ruiz; Matthew A Sparks; Ming Yan; David N Howell; Jose A Gomez; Robert F Spurney; Thomas M Coffman; Steven D Crowley
Journal:  Circ Res       Date:  2012-04-24       Impact factor: 17.367

3.  Increased serum levels of interleukin-1beta in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients?

Authors:  G N Dalekos; M Elisaf; E Bairaktari; O Tsolas; K C Siamopoulos
Journal:  J Lab Clin Med       Date:  1997-03

4.  Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo.

Authors:  Shalin H Naik; Priyanka Sathe; Hae-Young Park; Donald Metcalf; Anna I Proietto; Aleksander Dakic; Sebastian Carotta; Meredith O'Keeffe; Melanie Bahlo; Anthony Papenfuss; Jong-Young Kwak; Li Wu; Ken Shortman
Journal:  Nat Immunol       Date:  2007-10-07       Impact factor: 25.606

5.  Interleukin-6 inhibition attenuates hypertension and associated renal damage in Dahl salt-sensitive rats.

Authors:  Shireen Hashmat; Nathan Rudemiller; Hayley Lund; Justine M Abais-Battad; Scott Van Why; David L Mattson
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-08

6.  Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension.

Authors:  Antony Vinh; Wei Chen; Yelena Blinder; Daiana Weiss; W Robert Taylor; Jörg J Goronzy; Cornelia M Weyand; David G Harrison; Tomasz J Guzik
Journal:  Circulation       Date:  2010-11-29       Impact factor: 29.690

7.  Angiotensin II and salt-induced decompensation in Balb/CJ mice is aggravated by fluid retention related to low oxidative stress.

Authors:  Sofia Jönsson; Mediha Becirovic-Agic; Henrik Isackson; Maria K Tveitarås; Trude Skogstrand; Fredrik Narfström; Tine V Karlsen; Åsa Lidén; Sabine Leh; Madelene Ericsson; Stefan K Nilsson; Rolf K Reed; Michael Hultström
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-20

Review 8.  Infiltrating immune cells in the kidney in salt-sensitive hypertension and renal injury.

Authors:  David L Mattson
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-09

Review 9.  Inflammation in Salt-Sensitive Hypertension and Renal Damage.

Authors:  Xiaohan Lu; Steven D Crowley
Journal:  Curr Hypertens Rep       Date:  2018-10-30       Impact factor: 5.369

10.  Dendritic Cell Amiloride-Sensitive Channels Mediate Sodium-Induced Inflammation and Hypertension.

Authors:  Natalia R Barbaro; Jason D Foss; Dmytro O Kryshtal; Nikita Tsyba; Shivani Kumaresan; Liang Xiao; Raymond L Mernaugh; Hana A Itani; Roxana Loperena; Wei Chen; Sergey Dikalov; Jens M Titze; Bjorn C Knollmann; David G Harrison; Annet Kirabo
Journal:  Cell Rep       Date:  2017-10-24       Impact factor: 9.423

View more
  15 in total

Review 1.  Kidney dendritic cells: fundamental biology and functional roles in health and disease.

Authors:  Christian Kurts; Florent Ginhoux; Ulf Panzer
Journal:  Nat Rev Nephrol       Date:  2020-05-05       Impact factor: 28.314

2.  Type 1 Angiotensin Receptors on CD11c-Expressing Cells Protect Against Hypertension by Regulating Dendritic Cell-Mediated T Cell Activation.

Authors:  Xiaohan Lu; Jiandong Zhang; Yi Wen; Jiafa Ren; Robert Griffiths; Nathan P Rudemiller; Shintaro Ide; Tomokazu Souma; Steven D Crowley
Journal:  Hypertension       Date:  2022-04-18       Impact factor: 10.190

3.  Deficiency of MicroRNA-181a Results in Transcriptome-Wide Cell-Specific Changes in the Kidney and Increases Blood Pressure.

Authors:  Francine Z Marques; Geoffrey A Head; Madeleine R Paterson; Kristy L Jackson; Malathi S I Dona; Gabriella E Farrugia; Bruna Visniauskas; Anna M D Watson; Chad Johnson; Minolfa C Prieto; Roger G Evans; Fadi J Charchar; Alexander R Pinto
Journal:  Hypertension       Date:  2021-09-20       Impact factor: 10.190

Review 4.  Dendritic Cell Epithelial Sodium Channel in Inflammation, Salt-Sensitive Hypertension, and Kidney Damage.

Authors:  Lale A Ertuglu; Annet Kirabo
Journal:  Kidney360       Date:  2022-06-27

Review 5.  Should Renal Inflammation Be Targeted While Treating Hypertension?

Authors:  Sarika Chaudhari; Grace S Pham; Calvin D Brooks; Viet Q Dinh; Cassandra M Young-Stubbs; Caroline G Shimoura; Keisa W Mathis
Journal:  Front Physiol       Date:  2022-06-13       Impact factor: 4.755

Review 6.  The Immune System in Hypertension: a Lost Shaker of Salt 2021 Lewis K. Dahl Memorial Lecture.

Authors:  Xiaohan Lu; Steven D Crowley
Journal:  Hypertension       Date:  2022-05-12       Impact factor: 9.897

7.  Adverse Maternal and Fetal Outcomes in a Novel Experimental Model of Pregnancy after Recovery from Renal Ischemia-Reperfusion Injury.

Authors:  Ellen E Gillis; Michael W Brands; Jennifer C Sullivan
Journal:  J Am Soc Nephrol       Date:  2021-01-06       Impact factor: 10.121

Review 8.  Actions of immune cells in the hypertensive kidney.

Authors:  Xiaohan Lu; Steven D Crowley
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-09       Impact factor: 3.416

Review 9.  Immunity and Hypertension.

Authors:  Rong M Zhang; Kyle P McNerney; Amy E Riek; Carlos Bernal-Mizrachi
Journal:  Acta Physiol (Oxf)       Date:  2020-06-25       Impact factor: 6.311

10.  Neutrophil to Lymphocyte Ratio Is Increased and Associated With Left Ventricular Diastolic Function in Newly Diagnosed Essential Hypertension Children.

Authors:  Miao Hou; Lei Cao; Yueyue Ding; Ye Chen; Bo Wang; Jie Shen; Wanping Zhou; Jie Huang; Qiuqin Xu; Haitao Lv; Ling Sun
Journal:  Front Pediatr       Date:  2021-05-19       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.